Advertisement

Hospital Morbidity Database for Epidemiological Studies on Churg-Strauss Syndrome

  • Krzysztof KaneckiEmail author
  • Aneta Nitsch-Osuch
  • Paweł Gorynski
  • Patryk Tarka
  • Piotr Tyszko
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 980)

Abstract

Churg-Strauss syndrome or more accurately eosinophilic granulomatosis with polyangiitis (EGPA) is a small-vessel necrotizing vasculitis with a characteristic late-onset allergic rhinitis and asthma. The use of hospital morbidity database is an important element of the epidemiological analysis of this rare disease. The present study was undertaken to assess the incidence of EGPA and factors related to its epidemiology in Poland; the first analysis of the kind in Poland, enabling a comparison in the European context. This is a retrospective, population-based study using hospital discharge records with EGPA diagnosis, collected for a National Institute of Public Health survey covering the period from 2008 to 2013. The group consisted of 344 patients (206 females and 138 males) with the first-time hospitalization for EGPA. The major findings are that the annual incidence of EGPA in Poland was 1.5 per million (95% confidence intervals: 1.2–1.8), with the point prevalence of 8.8 per million at the end of 2013. A greater incidence of EGPA was observed in the regions with urban predominance. We conclude that discharge records may be a useful element of epidemiological studies on EGPA.

Keywords

ANCA-associated Disease prevalence Eosinophilic granulomatosis Epidemiology Morbidity Polyangiitis Vasculitis 

Notes

Conflicts of Interest

Authors declare no conflict of interest in relation to this article.

References

  1. Abramson JH (2011) WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Perspect Innov 8(1):1CrossRefPubMedPubMedCentralGoogle Scholar
  2. Bernatsky S, Joseph L, Pineau CA, Belisle P, Boivin JF, Banerjee D, Clarke AE (2009) Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences. Ann Rheum Dis 68:1192–1196CrossRefPubMedGoogle Scholar
  3. Bernatsky S, Lix L, Hanly JG, Hudson M, Badley E, Peschken C, Pineau CA, Clarke AE, Fortin PR, Smith M et al (2011) Surveillance of systemic autoimmune rheumatic diseases using administrative data. Rheumatol Int 31:549–554CrossRefPubMedGoogle Scholar
  4. Bloch DA, Michel BA, Hunder GG, McShane DJ, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Fries JF, Leavitt RY et al (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum 33(8):1068–1073CrossRefPubMedGoogle Scholar
  5. Central Statistical Office of Poland. http://stat.gov.pl. Accessed 13 Oct 2016
  6. Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, Maurier F, Jouneau S, Bienvenu B, Puéchal X et al (2013) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Study Group cohort. Arthritis Rheum 65:270–281CrossRefPubMedGoogle Scholar
  7. Foocharoen C, Thavornpitak Y, Mahakkanukrauh A, Suwannaroj S, Nanagara R (2013) Admission rate and characteristics of hospitalized systemic connective tissue disorders: analysis from a nationwide Thailand healthcare database. Int J Rheum Dis 16:41–46CrossRefPubMedGoogle Scholar
  8. Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V, Dalhoff K, Dunogué B, Gross W, Holle J et al (2015) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med 26:545–553CrossRefPubMedGoogle Scholar
  9. Hasegawa W, Yamauchi Y, Yasunaga H, Sunohara M, Jo T, Matsui H, Fushimi K, Takami K, Nagase T (2015) Factors that predict in-hospital mortality in eosinophilic granulomatosis with polyangiitis. Allergy 70:585–590CrossRefPubMedGoogle Scholar
  10. Herlyn K, Buckert F, Gross WL, Reinhold-Keller E (2014) Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany. Rheumatology (Oxford) 53:882–889CrossRefGoogle Scholar
  11. HMDB (2016) European Hospital Morbidity Database. Copenhagen, WHO Regional Office for Europe. http://www.euro.who.int/en/data-and-evidence/databases/european-hospital-morbidity-database-hmdb2. Accessed on 16 Oct 2016
  12. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1–11CrossRefPubMedGoogle Scholar
  13. Lanham JG, Elkon KB, Pusey CD, Hughes GR (1984) Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 63:65–81CrossRefPubMedGoogle Scholar
  14. Mahr A, Guillevin L, Poissonnet M, Aymé S (2004) Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 51:92–99CrossRefPubMedGoogle Scholar
  15. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–1100CrossRefPubMedGoogle Scholar
  16. Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M (2007) Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46:1329–1337CrossRefGoogle Scholar
  17. Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M (2009) Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 48:1560–1565CrossRefGoogle Scholar
  18. Ormerod AS, Cook MC (2008) Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales. Intern Med J 38:816–823CrossRefPubMedGoogle Scholar
  19. Pamuk ON, Donmez S, Calayir GB, Pamuk GE (2016) The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey. Clin Rheumatol 35:2063–2071CrossRefPubMedGoogle Scholar
  20. Phillip R, Luqmani R (2008) Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol 26(5 Suppl 51):94–104Google Scholar
  21. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53:93–99CrossRefPubMedGoogle Scholar
  22. Romero-Gomez C, Aguilar-Garcia JA, Garcia-de-Lucas MD, Cotos-Canca R, Olalla-Sierra J, Garcia-Alegria JJ, Hernández-Rodríguez J (2015) Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies. Clin Exp Rheumatol 33(2 Suppl 89):11–18Google Scholar
  23. Sada KE, Amano K, Uehara R, Yamamura M, Arimura Y, Nakamura Y, Makino H, Research Committee on Intractable Vasculitides, the Ministry of Health, Labour, Welfare of Japan (2014) A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan. Mod Rheumatol 24:640–644CrossRefPubMedGoogle Scholar
  24. Sokolowska BM, Szczeklik WK, Wludarczyk AA, Kuczia PP, Jakiela BA, Gasior JA, Bartyzel SR, Rewerski PA, Musial J (2014) ANCA-positive and ANCA-negative phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA): outcome and long-term follow-up of 50 patients from a single Polish center. Clin Exp Rheumatol 32(3 Suppl 82):41–47Google Scholar
  25. Vinit J, Muller G, Bielefeld P, Pfitzenmeyer P, Bonniaud P, Lorcerie B, Besancenot JF (2011) Churg-Strauss syndrome: retrospective study in Burgundian population in France in past 10 years. Rheumat Int 31:587–593Google Scholar
  26. Ward MM (2004) Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983–2001. Arthritis Rheum 50:1122–1131CrossRefPubMedGoogle Scholar
  27. Watts RA, Scott DG, Jayne DR, Ito-Ihara T, Muso E, Fujimoto S, Harabuchi Y, Kobayashi S, Suzuki K, Hashimoto H (2008) Renal vasculitis in Japan and the UK--are there differences in epidemiology and clinical phenotype? Nephrol Dial Transplant 23:3928–3931CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Krzysztof Kanecki
    • 1
    Email author
  • Aneta Nitsch-Osuch
    • 1
  • Paweł Gorynski
    • 2
  • Patryk Tarka
    • 1
  • Piotr Tyszko
    • 1
  1. 1.Department of Social Medicine and Public HealthMedical University of WarsawWarsawPoland
  2. 2.National Institute of Public Health – National Institute of HygieneWarsawPoland

Personalised recommendations